Analysis of the characteristic features of psychosocial adaptation of patients with coronary heart disease to chronic heart failure

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

BACKGROUND: Psychosocial risk factors influence the development and progression of chronic heart failure. Early identification and correction of psychosocial risk factors can reduce their negative impact on the severity of heart failure.

AIM: To determine a set of clinical characteristics, socio-demographic indicators, personal and psychological characteristics of patients with coronary heart disease depending on the level of psychosocial adaptation to chronic heart failure.

MATERIAL AND METHODS: The study involved 120 patients with coronary heart disease and chronic heart failure. The “Questionnaire for assessing psychosocial adaptation of patients with coronary heart disease to chronic heart failure” developed by the authors was used. Based on the testing results, patients were divided into three groups: adapted, conditionally adapted and maladapted. The first group included 40 patients, the second — 65, and the third — 15. The severity of the clinical course of heart failure, adherence to therapy and the presence of comorbid pathology were assessed. The characteristics of personal response, the severity of neurotic states, a tendency toward type D personality, quality of life, level of social support, and cognitive functions were studied. The socio-demographic characteristics of the patients (age, gender, level of education, position held, level of earnings, nature of alcohol consumption) were analyzed. Statistical and correlation data analysis was performed using the statistical computing environment R 4.2.1. The critical level of significance was considered to be p=0.05.

RESULTS: The severity of heart failure decreased (τ=0.38, 95% confidence interval 0.25–0.50, p <0.0001); indicators of left ventricular ejection fraction (ρ=–0.46, 95% confidence interval from –0.59 to –0.30, p <0.0001) and quality of life (ρ=0.63, 95% confidence interval 0.51–0.73, p <0.0001) increased as the level of psychosocial adaptation increased. Adapted and maladapted patients differed in age (p=0.0411), level of education (p=0.0179), position (p=0.0217), personal (p <0.0001) and family (p=0.015) financial well-being, characteristics of personal response, severity of neurotic disorders, as well as the level of social support (p <0.05), adherence to treatment (p=0.0004). Type D personality was registered in 100% of maladapted patients. Adapted patients had higher values of cognitive functions (26.5±4.2 points) and lower comorbidity index scores (5.8±2.7 points) than maladapted patients (23.6±2.3 points, p=0.003; 8.7±3.6 points, p=0.0033).

CONCLUSION: Differences in the severity of the clinical course of the disease, socio-demographic characteristics, personal and psychological characteristics of patients with coronary heart disease were found as the level of psychosocial adaptation to heart failure decreased.

Full Text

Restricted Access

About the authors

Alexander G. Zhidyaevskij

Kazan State Medical University

Author for correspondence.
Email: zhidyaevskij@mail.ru
ORCID iD: 0000-0002-4245-5201
SPIN-code: 5865-6771
Scopus Author ID: 57217636256
ResearcherId: ABE-5593-2020

MD, Cand. Sci. (Med.), Assistant, Depart. of Psychiatry and Medical Psychology

Russian Federation, Kazan

Genshat S. Galyautdinov

Kazan State Medical University

Email: galgen077@mail.ru
ORCID iD: 0000-0001-7403-0200
SPIN-code: 3626-0533
Scopus Author ID: 6507148532
ResearcherId: АБЕ-6977-2020

MD, Dr. Sci. (Med.), Prof., Department of Hospital Therapy

Russian Federation, Kazan

Vladimir D. Mendelevich

Kazan State Medical University

Email: mendelevich_vl@mail.ru
ORCID iD: 0000-0001-8489-3130
SPIN-code: 2302-2590
Scopus Author ID: 6602765981
ResearcherId: О-4908-2016

MD, Dr. Sci. (Med.), Prof., Head of Depart., Depart. of Psychiatry and Medical Psychology

Russian Federation, Kazan

References

  1. WHO.int. World Health Organization. Noncommunicable diseases. Information bulletin 2023. Available from: https://www.who.int/ru/news-room/fact-sheets/detail/noncommunicable-diseases Accessed: Feb 12, 2024.
  2. WHO.int. World Health Organization. The top 10 causes of death. Information bulletin 2020. Available from: https://www.who.int/ru/news-room/fact-sheets/detail/the-top-10-causes-of-death Accessed: Feb 12, 2024.
  3. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–1858. doi: 10.1016/S0140-6736(18)32279-7
  4. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211–1259. doi: 10.1016/S0140-6736(17)32154-2
  5. Russian Society of Cardiology. 2020 Clinical practice guidlines for Chronic heart failure. Russian Journal of Cardiology. 2020;25(11):311–374. (In Russ.) doi: 10.15829/1560-4071-2020-4083
  6. Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev. 2017;3(1):7–11. doi: 10.15420/cfr.2016:25:2
  7. Drapkina OM, Boytsov SA, Omelyanovskiy VV, Kontsevaya AV, Loukianov MM, Ignatieva VI, Derkach EV. Socio-economic impact of heart failure in Russia. Russian Journal of Cardiology. 2021;26(6):44–90. (In Russ.) doi: 10.15829/1560-4071-2021-4490
  8. Drapkina OM, Fedin AI, Dorofeeva OA, Medvedev VE, Kareva EN, Dzhioeva ON, Kuklin SG, Solovieva ЕYu, Abdulganieva DI, Kim ZF, Grigorovich MS, Shaposhnik II, Koryagina NА, Seredenin SB. Influence of psychosocial risk factors on the course and prognosis of cardiovascular diseases. Cardiovascular Therapy and Prevention. 2022;21(5):32–80. (In Russ.) doi: 10.15829/1728-8800-2022-3280
  9. Oganov RG, Maslennikova GY. The epidemics of cardiovascular diseases can be stopped by strengthening their prevention. Preventive medicine. 2009;12(6):3–7. (In Russ.) EDN: LFUCCT
  10. Drapkina OM, Kontsevaya AV, Kalinina AM, Avdeev SN, Agaltsov MV, Alexandrova LM, Antsiferova AA, Aronov DM, Akhmedzhanov NM, Balanova YuA, Balakhonova TV, Berns SA, Bochkarev MV, Bochkareva EV, Bubnova MG, Budnevsky AV, Gambaryan MG, Gorbunov VM, Gorny BE, Gorshkov AYu, Gumanova NG, Dadaeva VA, Drozdova LYu, Egorov VA, Eliashevich SO, Ershova AI, Ivanova ES, Imaeva AE, Ipatov PV, Kaprin AD, Karamnova NS, Kobalava ZhD, Konradi AO, Kopylova OV, Korostovtseva LS, Kotova MB, Kulikova MS, Lavrenova EA, Lischenko OV, Lopatina MV, Lukina YuV, Lukyanov MM, Mayev IV, Mamedov MN, Markelova SV, Martsevich SYu, Metelskaya VA, Meshkov AN, Milushkina OYu, Mukaneeva DK, Myrzamatova AO, Nebieridze DV, Orlov DO, Poddubskaya EA, Popovich MV, Popovkina OE, Potievskaya VI, Prozorova GG, Rakovskaya YuS, Rotar OP, Rybakov IA, Sviryaev YuV, Skripnikova IA, Skoblina NA, Smirnova MI, Starinsky VV, Tolpygina SN, Usova EV, Khailova ZhV, Shalnova SA, Shepel RN, Shishkova VN, Yavelov IS, Mardanov BU. 2022 Prevention of chronic non-communicable diseases in the Russian Federation. National guidelines. Cardiovascular Therapy and Prevention. 2022;21(4):5–232. (In Russ.) doi: 10.15829/1728-8800-2022-3235
  11. Pushkarev GS, Matskeplishvili ST. Psychosocial risk factors in cardiac practice. Patologiya krovoobrashcheniya i kardiokhirurgiya. 2021;25(4):30–40. (In Russ.) doi: 10.21688/1681-3472-2021-4-30-40
  12. Galyautdinov GS, Mendelevich VD, Zhidyaevskiy AG, Nesterina MK. Psychosocial adaptation of patients with chronic cardiovascular disease. The Bulletin of Contemporary Clinical Medicine. 2023;16(1):80–88. (In Russ.) doi: 10.20969/VSKM.2023.16(1).80-88
  13. Zhidyaevskij AG, Galyautinov GS, Mendelevich VD, Gataullina AG, Kuzmenko AO. Psychosocial adaptation to chronic heart failure in patients with coronary heart disease. Kazan Medical Journal. 2021;102(2):156–166. (In Russ). doi: 10.17816/KMJ2021-156
  14. Zhidyaevskii AG, Galiautdinov GS, Mendelevich VD, Nesterina MK. Method for determining the psychosocial adaptation of patientswith coronary heart disease to chronic heart failure. Patent RUS No. 2794026. Byul. No. 11 from 11.04.2023. (In Russ.) EDN: YONZFP
  15. Arakelyan MG, Bokeria LA, Vasilieva EY, Golitsyn SP, Golukhova EZ, Gorev MV, Davtyan KV, Drapkina OM, Kropacheva ES, Kuchinskaya EA, Lajovich LYu, Mironov NYu, Mishina IE, Panchenko EP, Revishvili ASh, Rzayev FG, Tatarsky BA, Utsumueva MD, Shakhmatova OO, Shlevkov NB, Shpektor AV, Andreev DA, Artyukhina EA, Barbarash OL, Galyavich AS, Duplyakov DV, Zenin SA, Lebedev DS, Mikhailov EN, Novikova NA, Popov SV, Filatov AG, Shlyakhto EV, Shubik YuV. 2020 Clinical guidelines for Atrial fibrillation and atrial flutter. Russian Journal of Cardiology. 2021;26(7):190–260. (In Russ). doi: 10.15829/1560-4071-2021-4594
  16. Sumin AN, Shcheglova AV. Is the concept of type D personality a component of personalized medicine or a prognostic factor in the treatment of cardiovascular diseases? Russian Journal of Cardiology. 2020;25(9):83–91. (In Russ.) doi: 10.15829/1560-4071-2020-3996

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Methods of assessing the clinical course of the disease, mental and social adaptation of patients; CHD — coronary heart disease; CHF — chronic heart failure; AUDIT-C — abbreviated version of the alcohol use assessment test; FС — functional class; RSCS — rating scale of clinical state; LVEF — left ventricular ejection fraction; AMPQ — abbreviated multifactor personality questionnaire; MLHFQ — the Minnesota living with heart failure questionnaire; MSPSS — multidimensional scale of perceived social support; MMSE — mini-mental state examination; DS14 — test to identify patients with the presence of personality type D

Download (157KB)
3. Fig. 2. Personality profile of patients of the studied groups

Download (39KB)
4. Fig. 3. Adherence to therapy of patients in the study groups

Download (27KB)

© 2024 Eco-Vector





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies